Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage <mml:math><mml:mi>B</mml:mi></mml:math>-Cell Chronic Lymphocytic Leukemia
<p>Syndecan-1 (CD138) is a transmembrane heparin sulfate proteoglycan expressed on distinct stages of differentiation of <mml:math><mml:mi>B</mml:mi></mml:math>-lymphoid cells. Its prognostic value in <mml:math><mml:mi>B</mml:mi></mml:math>-cell...
Saved in:
Format: | Article |
---|---|
Language: | English |
Published: |
Wiley
2006-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://www.hindawi.com/GetArticle.aspx?doi=10.1155/MI/2006/42394 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!